Page last updated: 2024-10-29

imipramine and Andersen Syndrome

imipramine has been researched along with Andersen Syndrome in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Andersen Syndrome: A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bigelow, AM1
Khalifa, MM1
Clark, JM1

Other Studies

1 other study available for imipramine and Andersen Syndrome

ArticleYear
Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
    Heart rhythm, 2015, Volume: 12, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Adult; Andersen Syndrome; Cholinesterase Inhibitors; Defibrillators, I

2015